NPPA notified regarding the computation of the retail price of Gliclazide IP 60mg (in modified release form) + Metformin Hydrochloride IP 500mg (in extended-release form) for M/s Mascot Health series Pvt. Ltd. (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer)

Jan 07, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on January 06, 2026, notified regarding the computation of the retail price of Gliclazide IP 60mg (in modified release form) + Metformin Hydrochloride IP 500mg (in extended-release form) for M/s Mascot Health series Pvt. Ltd. (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer).

It states that the price of each uncoated bi-layered tablet containing:- Gliclazide IP 60mg (in modified release form) + Metformin Hydrochloride IP 500mg (in extended-release form) for M/s Mascot Health series Pvt. Ltd. (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer) has been revised to Rs. 10.00/-.

[Notification no: 19(4952)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT